Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Wiener Klinische Wochenschrift|May 20, 2026
[Diabetic kidney disease (Update 2026) : Guidelines in a collaboration of the Austrian Diabetes Association and the Austrian Society of Nephrology]Harald Sourij, Felix Aberer, Marlies Antlanger, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 29, 2011
HSP27 and HSP70 serum and urine levels in patients suffering from chronic kidney diseaseDiana Lebherz-Eichinger, Hendrik J Ankersmit, Stefan Hacker, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 4, 2011
Increased total cytokeratin-18 serum and urine levels in chronic kidney diseaseGeorg A Roth, Diana Lebherz-Eichinger, Hendrik Jan Ankersmit, et al.
Wiener Klinische Wochenschrift|June 14, 2002
Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot studyMartin Haas, Gert Mayer, Gerhard Wirnsberger, et al.
Plos One|January 10, 2013
Nicotine promotes acquisition of stem cell and epithelial-to-mesenchymal properties in head and neck squamous cell carcinomaMichael Andrew Yu, Alan Kiang, Jessica Wang-Rodriguez, et al.
Plos One|October 3, 2013
Early human prostate adenocarcinomas harbor androgen-independent cancer cellsRita R Fiñones, Jo Yeargin, Melissa Lee, et al.
Kidney International|July 31, 2024
Augmentative effects of leukemia inhibitory factor reveal a critical role for TYK2 signaling in vascular calcificationIoana Alesutan, Mehdi Razazian, Trang T D Luong, et al.
Wiener Klinische Wochenschrift|October 2, 2024
[Osteoporosis-Definition, risk assessment, diagnosis, prevention and treatment (update 2024) : Guidelines of the Austrian Society for Bone and Mineral Research]Hans Peter Dimai, Christian Muschitz, Karin Amrein, et al.
Plos One|March 3, 2012
EGFR kinase promotes acquisition of stem cell-like properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cellsEric L Abhold, Alan Kiang, Elham Rahimy, et al.
Trials|March 23, 2023
A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideITFrederik Haupenthal, Jette Rahn, Fabrizio Maggi, et al.
Pageof 13